AwardedPRTGoods€29,600
251A000052 - VIII - USTECINUMAB 130 MG SOL INJ IV FR 26 ML BIOSSIMILAR (PYZCHIVA)
- Published
- Published 27 May 2025
Overview
251A000052 - VIII - USTECINUMAB 130 MG SOL INJ IV FR 26 ML BIOSSIMILAR (PYZCHIVA)
Key details
- Country
- PRT
- Status
- Awarded
- Category
- Goods
- Estimated value
- €29,600
- Procedure
- Open
- Published
- 27 May 2025
Immune sera and immunoglobulins
Award outcome
- Awarded value
- €29,600
- Award date
- 22 April 2025
- Contract period
- — → 18 December 2025
- Sandoz Farmaceutica, Lda
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
27 May 2025
Contracting authority
Unidade Local de Saúde Santa Maria, E.P.E.
Procuring entityLisboa, PRT
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.